UPDATE 1-Hikma reaffirms full-year revenue forecast, cites better generics business

May 18 (Reuters) - Hikma Pharmaceuticals Plc on Friday reaffirmed its revenue guidance for the full year, noting its generics business was performing better due to a favourable product mix, despite continued pricing pressure in the United States.